ARK Investment Management LLC 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-10 9:46 pm Sale | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 6,531,099 7.920% | -2,862,790 (-30.48%) | Filing |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 9,393,889 11.530% | 1,180,758 (+14.38%) | Filing |
| 2023-02-10 11:48 am Purchase | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 8,213,131 11.650% | 229,730 (+2.88%) | Filing |
| 2022-02-09 2:05 pm Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 7,983,401 11.720% | 1,676,852 (+26.59%) | Filing |
| 2021-06-10 1:14 pm Purchase | 2021-05-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 6,306,549 10.080% | 6,306,549 (New Position) | Filing |